The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis

Journal of the Neurological Sciences

Volumn 334, Issue 1-2, 2013, Pages 6-9

  Živković, Maja ^a   Životić, Ivan ^a   Dinčić, Evica ^b   Stojković, Ljiljana ^a   Vojinović, Slobodan ^c   Stanković, Aleksandra ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c CLINICAL CENTER NI   (Serbia)

Author keywords

Antioxidant defense; Deletion; Gene polymorphism; Glutathione S transferase M1; Glutathione S transferase T1; Multiple sclerosis

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANTIOXIDANT DEFENSE; DELETION; GENE POLYMORPHISM; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; MULTIPLE SCLEROSIS;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

EID: 84887493190     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.07.001     Document Type: Article

References (40)

1. C.F. Lucchinetti, W. Brueck, M. Rodriguez, and H. Lassmann Semin multiple sclerosis: lessons from neuropathology Neurology 18 1998 337 349
2. V. Siffrin, J. Vogt, H. Radbruch, R. Nitsch, and F. Zipp Multiple sclerosis: candidate mechanisms underlying CNS atrophy Trends Neurosci 33 2010 202 210
3. N. De Stefano, P.M. Matthews, M. Filippi, F. Agosta, M. De Luca, and M.L. Bartolozzi Evidence of early cortical atrophy in MS: relevance to white matter changes and disability Neurology 60 2003 1157 1162
4. O. Vladimirova, J. O'Connor, A. Cahill, H. Alder, C. Butunoi, and B. Kalman Oxidative damage to DNA in plaques of MS brains Mult Scler 4 1998 413 418
5. J. Qin, R. Goswami, R. Balabanov, and G. Dawson Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain J Neurosci Res 85 2007 977 984
6. J. Van Horssen, M.E. Witte, G. Schreibelt, and H.E. de Vries Radical changes in multiple sclerosis pathogenesis Biochem Biophys Acta 2011 1812 141 150
7. L. Haider, M.T. Fischer, J.M. Frischer, J. Bauer, R. Höftberger, and G. Botond Oxidative damage in multiple sclerosis lesions Brain 134 2011 1914 1924
8. H. Lassmann, and J. van Horssen The molecular basis of neurodegeneration in multiple sclerosis FEBS Lett 585 2011 3715 3723
9. M.C.J. Wilce, and M.W. Parker Structure and function of glutathione S-transferases Biochim Biophys Acta 1205 1994 1 18
10. J.D. Hayes, and D.J. Pulford The glutathione S-transferase supergene family: regulation of GST and the contributions of the isoenzymes to cancer chemoprotection and drug resistance CRC Crit Rev Biochem Mol Biol 30 1995 445 600
11. D. Sheenan, G. Meade, V.M. Foley, and C.A. Dowd Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily Biochem J 360 2001 1 16
12. J.D. Hayes, J.U. Flanagan, and I.R. Jowsey Glutathione transferases Annu Rev Pharmacol Toxicol 45 2005 51 88
13. S.R. Oliveira, A.P. Kallaur, A.N.C. Simao, H.K. Morimoto, J. Lopes, and C. Panis Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale J Neurol Sci 321 2012 49 53
14. T.R. Rebbeck Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility Cancer Epidemiol Biomarkers Prev 6 1997 733 743
15. S. Pemble, K.R. Schroeder, S.R. Spencer, D.J. Meyer, E. Hallier, and H.M. Bolt Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism Biochem J 300 1994 271 276
16. C.L. Mann, M.B. Davies, M.D. Boggild, J. Alldersea, A.A. Fryer, and P.W. Jones Glutatione S-transferase polymorfisms in MS: their relationship to disability Neurology 5 2000 542 544
17. C.H. Polman, S.C. Reingold, B. Banwell, M. Clanet, J.A. Cohen, and M. Filippi Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann Neurol 69 2011 292 302
18. D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis Neurology 46 1996 907 911
19. R.H. Roxburgh, S.R. Seaman, T. Masterman, A.E. Hensiek, S.J. Sawcer, and S. Vukusic Multiple sclerosis severity score: using disability and disease duration to rate disease severity Neurology 64 2005 1144 1151
20. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
21. H. Chen, D.P. Sandler, J.A. Taylor, D.L. Shore, E. Liu, and C.D. Bloomfield Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect Lancet 347 1996 295 297
22. K.J. Helzlsouer, O. Selmin, H.Y. Huang, P.T. Strickland, S. Hoffman, and A.J. Alberg Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer J Natl Cancer Inst 90 1998 512 518
23. W.D. Dupont, and W.D. Plummer Power and sample size calculations: a review and computer program Control Clin Trials 11 1990 116 128
24. H.H. Nelson, J.K. Wiencke, D.C. Christiani, T.J. Cheng, Z.F. Zuo, and B.S. Schwartz Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S transferase theta Carcinogenesis 16 1995 1243 1245
25. S. Garte, L. Gaspari, A.K. Alexandrie, C. Ambrosone, H. Autrup, and J.L. Autrup Metabolic gene polymorphism frequencies in control populations Cancer Epidemiol Biomarkers Prev 10 2001 1239 1248
26. C. Stavropoulou, D. Korakaki, H. Rigana, G. Voutsinas, M. Polyzoi, and V.N. Georgakakos Glutathione-S-transferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: a pilot study Eur J Neurol 14 2007 572 574
27. S. Ljubisavljevic, I. Stojanovic, S. Vojinovic, D. Stojanov, S. Stojanovic, and T. Cvetkovic The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in sera and csf Neurochem Int 2013 10.1016/j.neuint.2013.02.025 [pii: S0197-0186(13)00070-3, Epub ahead of print]
28. K. Mitosek-Szewczyk, W. Gordon-Krajcer, P. Walendzik, and Z. Stelmasiak Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy Folia Neuropathol 48 2010 116 122
29. V. Calabrese, G. Scapagnini, A. Ravagna, R. Bella, D.A. Butterfield, and M. Calvani Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine Neurochem Res 28 2003 1321 1328
30. M. Lucas, M.C. Rodríguez, J.M. Gata, M.D. Zayas, F. Solano, and G. Izquierdo Regulation by interferon beta-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patients Neurochem Int 42 2003 67 71
31. I. Stojanovic, S. Vojinovic, S. Ljubisavljevic, R. Pavlovic, J. Basic, and D. Pavlovic INF-β1b therapy modulates l-arginine and nitric oxide metabolism in patients with relapse remittens multiple sclerosis J Neurol Sci 323 2013 187 192
32. J.J. Lochhead, G. McCaffrey, C.E. Quigley, J. Finch, K.M. DeMarco, and N. Nametz Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation J Cereb Blood Flow Metab 30 2010 1625 1636
33. A. Ahmadi, M. Fredrikson, H. Jerregârd, A. Akerbäck, P.A. Fall, and A. Rannug GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset Biochem Biophys Res Commun 269 2000 676 680
34. C. Perez-Pastene, R. Graumann, F. Díaz-Grez, M. Miranda, P. Venegas, and O.T. Godoy Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component Neurosci Lett 418 2007 181 185
35. F.D. Dick, G. De Palma, A. Ahmadi, A. Osborne, N.W. Scott, and G.J. Prescott Geoparkinson study group. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study Occup Environ Med 64 2007 673 680
36. A. Horska, C. Mislanova, S. Bonassi, M. Ceppi, K. Volkovova, and M. Dusinska Vitamin C levels in blood are influenced by polymorphisms in glutathione S-transferases Eur J Nutr 50 2010 437 446
37. G. Block, N. Shaikh, C.D. Jensen, V. Volberg, and N. Holland Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT1 Am J Clin Nutr 94 2011 929 937
38. M. Dusinska, M. Staruchova, A. Horska, B. Smolkova, A. Collins, and S. Bonassi Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies Mutat Res 736 2012 130 137
39. M.T. Fischer, I. Wimmer, R. Höftberger, S. Gerlach, L. Haider, and T. Zrzavy Disease-specific molecular events in cortical multiple sclerosis lesions Brain 136 2013 1799 1815
40. E. Laborde Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death Cell Death Differ 17 2010 1373 1380